Conference Coverage
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
181-195 of 582
Beyond Disease Control: PROs With Odronextamab in R/R Follicular Lymphoma
Project Oncology®Beyond Disease Control: PROs With Odronextamab in R/R Follicular Lymphoma
Ryan Quigley
Clemastine Fumarate and Progressive MS: A Closer Look at Unexpected Risks and Mechanisms
NeuroFrontiersClemastine Fumarate and Progressive MS: A Closer Look at Unexpected Risks and Mechanisms
Targeting CD19 in Autoimmune Neuropathy: Case Report Insights
Living RheumTargeting CD19 in Autoimmune Neuropathy: Case Report Insights
Examining Real-World Ibrutinib Outcomes in R/R MCL: Findings from a Danish Study
Project Oncology®Examining Real-World Ibrutinib Outcomes in R/R MCL: Findings from a Danish Study
Marlene Mimi Maeusli, PhD.
Reimagining Autoimmune Care with CAR-Based Cell Therapies
Living RheumReimagining Autoimmune Care with CAR-Based Cell Therapies
Expanding the Risk Profile: Genetic Insights Into Lung Cancer in Non-Smokers
Project Oncology®Expanding the Risk Profile: Genetic Insights Into Lung Cancer in Non-Smokers
Paola Marignani, PhD, EMBA
- advertisement
From Policy to Practice: What the WHO Lung Health Resolution Means for Lung Cancer Care
Project Oncology®From Policy to Practice: What the WHO Lung Health Resolution Means for Lung Cancer Care
Ryan Quigley
Unlocking Tumor Complexity: Single-Cell RNA Sequencing in Lung Cancer
Project Oncology®Unlocking Tumor Complexity: Single-Cell RNA Sequencing in Lung Cancer
Paola Marignani, PhD, EMBA
The SMART Protocol in Mesothelioma: Challenges and Opportunities for Global Adoption
Project Oncology®The SMART Protocol in Mesothelioma: Challenges and Opportunities for Global Adoption
John Cho, MD, PhD, FRCPC
Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing
Project Oncology®Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing
John Cho, MD, PhD, FRCPC
Ibrutinib-Venetoclax in Relapsed CLL: MRD-Guided Approach Balances Efficacy and Safety
Project Oncology®Ibrutinib-Venetoclax in Relapsed CLL: MRD-Guided Approach Balances Efficacy and Safety
Prognostic Value of Red Cell Distribution Width at Ruxolitinib Initiation in Myelofibrosis
Project Oncology®Prognostic Value of Red Cell Distribution Width at Ruxolitinib Initiation in Myelofibrosis
- advertisement
Addressing Psychological Distress in Lung Cancer: The Emerging Role of EMDR Therapy
Project Oncology®Addressing Psychological Distress in Lung Cancer: The Emerging Role of EMDR Therapy
Targeting CCR4 in CAR-Associated Peripheral T-Cell Lymphoma
Project Oncology®Targeting CCR4 in CAR-Associated Peripheral T-Cell Lymphoma
Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
Project Oncology®Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
